Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07768800
NA

Evaluation of Dermal Acceptability and Comedogenic and Acnegenic Potential of a Cosmetic Product

Sponsor: Brainfarma Industria Química e Farmacêutica S/A

View on ClinicalTrials.gov

Summary

This is a single-center, single-blind clinical study designed to evaluate the dermatological safety of a cosmetic product and to demonstrate the absence of comedogenic and acnegenic potential. A total of 33 female participants, aged 18 to 60 years, with oily and acne-prone skin will be enrolled. Participants will use the investigational product for 28 days under normal conditions of use. Dermatological safety, skin tolerability, and the absence of comedogenic and acnegenic effects will be assessed throughout the study period by clinical evaluations conducted according to the study protocol.

Official title: Clinical Evaluation of Dermal Acceptability and the Comedogenic and Acnegenic Potential of a Cosmetic Product

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

33

Start Date

2026-07-20

Completion Date

2026-09-17

Last Updated

2026-08-17

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

Blancy Pro

Blancy Pro is a cosmetic product intended for daily use in individuals with oily and acne-prone skin. Participants will use the product for 28 days under normal conditions of use. Dermatological safety and the absence of comedogenic and acnegenic potential will be evaluated through clinical assessments.

Locations (1)

Grupo Medcin

Osasco, São Paulo, Brazil